The effect of Venlafaxine on the neuro-behavioral status of mice after administration of chemotherapeutic-neurotoxic agent (Cyclophosphamide)

Main Article Content

Maha Elbeltagy https://orcid.org/0000-0002-4777-2388
Lujain AlZoubi https://orcid.org/0000-0003-1705-3363
Rand B. AbuAnzeh https://orcid.org/0000-0003-4585-1848
Mohammed Yousef https://orcid.org/0000-0001-9367-9347
Yara AlAdwan https://orcid.org/0009-0003-3263-7268
Raha AlZoubi https://orcid.org/0000-0002-5275-7967
Ahmed Salman https://orcid.org/0000-0002-2852-1751

Keywords

Cyclophosphamide, Venlafaxine, Cognition, Memory

Abstract

Background: Cyclophosphamide (CPH) is a cornerstone in cancer therapy and the present study explores the effect of Venlafaxine (VLX) against cognitive deficits induced by CPH in mice and its effect on neurogenesis in the hippocampus. Methods: Forty mice were randomly allocated to four groups: control, VLX, CPH, and CPH+VLX. The Novel Location Recognition model (NLR) test used here is a spatial variant of a two-trial object recognition task performed before and after the treatment with the drugs. Results: The control group, the VLX group, and the VLX and CPH group examined the object at the new location significantly more than the old one (P=0.04, P=0.05, and P=0.01, respectively). The test demonstrated a significant difference between Ki-67- positive cell numbers across the four groups (p < 0.0001). There was a significant decrease in the total number of Ki67-positive cells in the CPH group compared to the control group (p < 0.001). Conversely, the combined CPH and VLX group showed increased hippocampal proliferation compared to the CPH group (p < 0.001). There was a significant difference between GPX-1 positively stained cell numbers between control and CPH as well as control and CPH+VLX treated cells (p < 0.001) for both. Conclusion: our results show that CPH treatment caused cognitive deficits which were associated with a reduction in cell proliferation in dentate gyrus. These deficits were reduced when VLX was administered along with CPH.

Abstract 222 | PDF Downloads 110

References

1. Lee JH, Nan A.Combination drug delivery approaches in metastatic breast cancer. Journal of drug delivery. 2012;2012:915375. https://doi.org/10.1155/2012/915375
2. Ogino MH, Tadi P. Cyclophosphamide. In StatPearls. StatPearls Publishing. (2022).
3. Oraby HA, Hassan AA, Maaty NF. Effects of cyclophosphamide on transcription of SOD1 mRNA and GPX1 mRNA in mice liver and brain tissue. J Appl Biosci. 2010;29:1736-42.
4. Bhatia AL, Manda K, Patni S, Sharma AL. Prophylactic action of linseed (Linum usitatissimum) oil against cyclophosphamideinduced oxidative stress in mouse brain. Journal of medicinal food. 2006;9(2):261-4. https://doi.org/10.1089/jmf.2006.9.261
5. Kitamura Y, Kanemoto E, Sugimoto M, Machida A, Nakamura Y, Naito N, et al. Influence of nicotine on doxorubicin and cyclophosphamide combination treatment-induced spatial cognitive impairment and anxiety-like behavior in rats. Naunyn-Schmiedeberg’s archives of pharmacology.2017;390(4):369-78. https://doi.org/10.1007/s00210-016-1338-z
6. Ibrahim HM, Zommara MA, Elnaggar ME. Ameliorating effect of selenium nanoparticles on cyclophosphamide-induced hippocampal neurotoxicity in male rats: light, electron microscopic and immunohistochemical study. Folia morphologica. 2021;80(4):806-19. https://doi.org/10.5603/fm.a2020.0117
7. Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell biology and toxicology. 2007;23(5):303-12.
https://doi.org/10.1007/s10565-006-0078-0
8. Li L, Zhang C. Venlafaxine Attenuated the Cognitive and Memory Deficit in Mice Exposed to Isoflurane Alone. Frontiers in neurology. 2021;12:591223. https://doi.org/10.3389/fneur.2021.591223
9. Dawson LA, Nguyen HQ, Geiger A. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Neuropharmacology. 1999;38(8):1153-63.
https://doi.org/10.1016/s0028-3908(99)00052-0
10. Zepeda R, Contreras V, Pissani C, Stack K, Vargas M, Owen GI, et al. Venlafaxine treatment after endothelin-1-induced cortical stroke modulates growth factor expression and reduces tissue damage in rats. Neuropharmacology. 2016;107:131-45. https://doi.org/10.1016/j.neuropharm.2016.03.011
11. Lapmanee S, Charoenphandhu J, Teerapornpuntakit J, Krishnamra N, Charoenphandhu N. Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats.
PloS one. 2017;12(11):e0187671. https://doi.org/10.1371/journal.pone.0187671
12. Berlyne DE. Novelty and curiosity as determinants of exploratory behaviour. British journal of psychology. 1950;41(1):68.
13. Dix SL, Aggleton JP. Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition. Behavioural brain research. 1999;99(2):191-200. https://doi.org/10.1016/s0166-4328(98)00079-5
14. Mustafa S, Walker A, Bennett G, Wigmore PM. 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. The European journal of neuroscience.2008;28(2):323-30.
https://doi.org/10.1111/j.1460-9568.2008.06325.x
15. Bruel-Jungerman E, Laroche S, Rampon C. New neurons in the dentate gyrus are involved in the expression of enhanced longterm memory following environmental enrichment. The European journal of neuroscience. 2005;21(2):513-21. https://doi.
org/10.1111/j.1460-9568.2005.03875.x
16. ElBeltagy M, Mustafa S, Umka J, Lyons L, Salman A, Chur-yoe GT, et al. Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil. Behavioural brain research. 2010;208(1):112-7.
17. Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2012;30(30):3675-86. https://doi.org/10.1200/jco.2012.43.0116
18. Simó M, Rifà-Ros X, Rodriguez-Fornells A, Bruna J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neuroscience and biobehavioral reviews. 2013;37(8):1311-21. https://doi.org/10.1016/j.neubiorev.2013.04.015
19. McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast cancer research and treatment, 2010;123(3):819-28.
https://doi.org/10.1007/s10549-010-1088-4
20. Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, Van den Stock J, et al. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human brain
mapping2011;32(3):480-93. https://doi.org/10.1002/hbm.21033
21. Kreukels BP, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, Muller MJ, et al. Effects of high-dose and conventionaldose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.
Clinical breast cancer. 2006;7(1):67-78. https://doi.org/10.3816/cbc.2006.n.015
22. Kreukels BPC, Hamburger HL, de Ruiter MB, van Dam FSAM, Ridderinkhof KR, Boogerd W, et al. ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology. 2008;119(3):533-41. https://doi.org/10.1016/j.clinph.2007.11.011
23. Lapmanee S, Charoenphandhu J, Teerapornpuntakit J, Krishnamra N, Charoenphandhu N. Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats. PloS one. 2017;12(11):e0187671. https://doi.org/10.1371/journal.pone.0187671
24. Zhang X, Li X, Li M, Ren J, Yun K, An Y, et al. Venlafaxine increases cell proliferation and regulates DISC1, PDE4B and NMDA receptor 2B expression in the hippocampus in chronic mild stress mice. European journal of pharmacology. 2015;755:58-65.
https://doi.org/10.1016/j.ejphar.2015.02.044
25. Sasváriová M, Micháliková D, Kaprinay BT, Salvaras L, Hričáková S, Knezl V, et al. The effect of venlafaxine on blood pressure and ECG in rats fed with high-fat-fructose diet. Interdisciplinary toxicology. 2019;12(4):192-9. https://doi.org/10.2478/
intox-2019-0024
26. Imayoshi I, Sakamoto M, Ohtsuka T, Kageyama R. Continuous neurogenesis in the adult brain. Development, growth & differentiation. 2009;51(3):379-86. https://doi.org/10.1111/j.1440-169x.2009.01094.x
27. Jessberger S, Clark RE, Broadbent NJ, Clemenson GD Jr, Consiglio A, Lie DC, et al. Dentate gyrus-specific knockdown of adult neurogenesis impairs spatial and object recognition memory in adult rats. Learning & memory (Cold Spring Harbor, N.Y.).
2009;16(2):147-54. https://doi.org/10.1101/lm.1172609
28. Kodama M, Fujioka T, Duman RS. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biological psychiatry. 2004;56(8):570-80. https://doi.org/10.1016/j.biopsych.2004.07.008
29. Holick KA, Lee DC, Hen R, Dulawa SC. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology: official publication of the American College of
Neuropsychopharmacology. 2008;33(2):406-17. https://doi.org/10.1038/sj.npp.1301399
30. Cowen DS, Takase LF, Fornal CA, Jacobs BL. Age-dependent decline in hippocampal neurogenesis is not altered by chronic treatment with fluoxetine. Brain research. 2008;1228;14-19. https://doi.org/10.1016/j.brainres.2008.06.059
31. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. ‘Chemobrain’ in breast carcinoma?: a prologue. Cancer. 2004;101(3):466-75. https://doi.org/10.1002/cncr.20393
32. Konat GW, Kraszpulski M, James I, Zhang HT, Abraham J. Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats. Metabolic brain disease. 2008;23(3):325-33. https://doi.org/10.1007/s11011-008-9100-y
33. Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FS, et al. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behavioural brain research. 2008;186(2):168-75.
https://doi.org/10.1016/j.bbr.2007.08.004
34. Abdel-Wahab B, SalamaR. Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice.Pharmacol Biochem Behav. 2011;100(1):59-65 https://doi.org/10.1016/j.pbb.2011.07.015
35. Janelsins M, Roscoe J, Berg M, Thompson B, Gallagher M, Morrow G, et al. IGF-1 Partially Restores Chemotherapy-Induced Reductions in Neural Cell Proliferation in Adult C57BL/6 Mice. Cancer Invest. 2010;28(5):544-53. https://doi.
org/10.3109/07357900903405942
36. Gottlieb M, Leal-Campanario R, Campos-Esparza MR, Sánchez-Gómez MV, Alberdi E, Arranz A, et al. Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia. Neurobiology of disease. 2006;23(2):374-86. https://doi.
org/10.1016/j.nbd.2006.03.017
37. Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology. 2001;40(8):959-75. https://doi.org/10.1016/s0028-3908(01)00019-3
38. Oliveira R, Cunha G, Borges K, Bruin G, Santos-Filho E, Viana G, et al. The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats.
39. Carvalho,A. Sharma,M. Brunoni,A. Vieta,E. Fava,G. The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature. Psychother psychosom. 2016;85(5):270-88 https://doi.
org/10.1159/000447034
40. Zhang Z, Pan T, Liu C, Shan X, Xu Z, Hong H, et al. Cyclophosphamide induced physiological and biochemical changes in mice with an emphasis on sensitivity analysis. Ecotoxical Environ Saf. 2021 Mar 15:211:111889. https://doi.org/10.1016/j.
ecoenv.2020.111889
41. Kumamoto Y, Camporez JPG, Jurczak MJ, Shanabrough M, Horvath T, Shulman GI, et al. CD301b(+) mononuclear phagocytes maintain positive energy balance through secretion of resistin-like molecule alpha. Immunity. 2016;45(3):583-96. https://doi.
org/10.1016/j.immuni.2016.08.002